| Multifunctional liposomes reduce brain β-amyloid burden and ameliorate memory impairment in Alzheimer's disease mouse models C Balducci, S Mancini, S Minniti, P La Vitola, M Zotti, G Sancini, M Mauri, ... Journal of Neuroscience 34 (42), 14022-14031, 2014 | 178 | 2014 |
| Intranasal delivery of mesenchymal stem cell-derived extracellular vesicles exerts immunomodulatory and neuroprotective effects in a 3xTg model of Alzheimer's disease M Losurdo, M Pedrazzoli, C D'Agostino, CA Elia, F Massenzio, E Lonati, ... Stem cells translational medicine 9 (9), 1068-1084, 2020 | 172 | 2020 |
| Lorlatinib treatment elicits multiple on-and off-target mechanisms of resistance in ALK-driven cancer S Redaelli, M Ceccon, M Zappa, GG Sharma, C Mastini, M Mauri, ... Cancer research 78 (24), 6866-6880, 2018 | 93 | 2018 |
| SETBP1 induces transcription of a network of development genes by acting as an epigenetic hub R Piazza, V Magistroni, S Redaelli, M Mauri, L Massimino, A Sessa, ... Nature communications 9 (1), 2192, 2018 | 80 | 2018 |
| Mesenchymal stem cells enhance GABAergic transmission in co-cultured hippocampal neurons M Mauri, D Lentini, M Gravati, D Foudah, G Biella, B Costa, M Toselli, ... Molecular and Cellular Neuroscience 49 (4), 395-405, 2012 | 42 | 2012 |
| Light on the structure of thromboxane A2 receptor heterodimers F Fanelli, M Mauri, V Capra, F Raimondi, F Guzzi, M Ambrosio, ... Cellular and molecular life sciences 68, 3109-3120, 2011 | 32 | 2011 |
| ETNK1 mutations induce a mutator phenotype that can be reverted with phosphoethanolamine D Fontana, M Mauri, R Renso, M Docci, I Crespiatico, LM Røst, M Jang, ... Nature Communications 11 (1), 5938, 2020 | 31 | 2020 |
| Absent B cells, agammaglobulinemia, and hypertrophic cardiomyopathy in folliculin-interacting protein 1 deficiency F Saettini, C Poli, J Vengoechea, S Bonanomi, JC Orellana, G Fazio, ... Blood, The Journal of the American Society of Hematology 137 (4), 493-499, 2021 | 29 | 2021 |
| De novo UBE2A mutations are recurrently acquired during chronic myeloid leukemia progression and interfere with myeloid differentiation pathways V Magistroni, M Mauri, D D’Aliberti, C Mezzatesta, I Crespiatico, M Nava, ... haematologica 104 (9), 1789, 2019 | 24 | 2019 |
| In vitro and in vivo identification of ABCB1 as an efflux transporter of bosutinib S Redaelli, P Perini, M Ceccon, R Piazza, R Rigolio, M Mauri, F Boschelli, ... Journal of hematology & oncology 8, 1-10, 2015 | 23 | 2015 |
| Impaired thromboxane receptor dimerization reduces signaling efficiency: A potential mechanism for reduced platelet function in vivo V Capra, M Mauri, F Guzzi, M Busnelli, MR Accomazzo, P Gaussem, ... Biochemical pharmacology 124, 43-56, 2017 | 21 | 2017 |
| Superactive mutants of thromboxane prostanoid receptor: functional and computational analysis of an active form alternative to constitutively active mutants M Ambrosio, F Fanelli, S Brocchetti, F Raimondi, M Mauri, GE Rovati, ... Cellular and molecular life sciences 67, 2979-2989, 2010 | 21 | 2010 |
| Large-scale analysis of SARS-CoV-2 synonymous mutations reveals the adaptation to the human codon usage during the virus evolution D Ramazzotti, F Angaroni, D Maspero, M Mauri, D D’Aliberti, D Fontana, ... Virus evolution 8 (1), veac026, 2022 | 19 | 2022 |
| Plasma membrane cholesterol level and agonist-induced internalization of δ-opioid receptors; colocalization study with intracellular membrane markers of Rab family J Brejchova, M Vosahlikova, L Roubalova, M Parenti, M Mauri, ... Journal of bioenergetics and biomembranes 48, 375-396, 2016 | 18 | 2016 |
| Analysis of GPCR dimerization using acceptor photobleaching resonance energy transfer techniques M Busnelli, M Mauri, M Parenti, B Chini Methods in Enzymology 521, 311-327, 2013 | 16 | 2013 |
| Synergistic drug combinations prevent resistance in ALK+ anaplastic large cell lymphoma G Arosio, GG Sharma, M Villa, M Mauri, I Crespiatico, D Fontana, ... Cancers 13 (17), 4422, 2021 | 13 | 2021 |
| CD24/Siglec-10 “Don't Eat Me” signal blockade is a potential immunotherapeutic target in mantle-cell lymphoma A Aroldi, M Mauri, M Parma, E Terruzzi, M Fedele, P Perfetti, F Cocito, ... Blood 138, 2276, 2021 | 12 | 2021 |
| Case report: Hypomorphic function and somatic reversion in DOCK8 deficiency in one patient with two novel variants and sclerosing cholangitis F Saettini, G Fazio, D Moratto, M Galbiati, N Zucchini, D Ippolito, ... Frontiers in immunology 12, 673487, 2021 | 8 | 2021 |
| Effects of blocking CD24 and CD47 ‘don't eat me’signals in combination with rituximab in mantle‐cell lymphoma and chronic lymphocytic leukaemia A Aroldi, M Mauri, D Ramazzotti, M Villa, F Malighetti, V Crippa, F Cocito, ... Journal of Cellular and Molecular Medicine 27 (20), 3053-3064, 2023 | 7 | 2023 |
| A novel high-content immunofluorescence assay as a tool to identify at the single cell level γ-globin inducing compounds M Durlak, C Fugazza, S Elangovan, MG Marini, MF Marongiu, P Moi, ... Plos one 10 (10), e0141083, 2015 | 7 | 2015 |
